PAXIL CR
LOE Approachingparoxetine hydrochloride
NDAORALTABLET, EXTENDED RELEASE
Approved
Feb 1999
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
7
Mechanism of Action
(MDD), panic disorder (PD), social anxiety disorder (SAD), and premenstrual dysphoric disorder (PMDD) is unknown, but is presumed to be linked to potentiation of serotonergic activity in the central nervous system resulting from inhibition of neuronal reuptake of serotonin (5-HT).
Indications (1)
Clinical Trials (5)
Paxil CR Bioequivalence Study Brazil - Fed Administration
Started Oct 2009
60 enrolled
Depressive Disorder
Paxil CR Bioequivalence Study Brazil
Started Sep 2009
60 enrolled
Depressive Disorder
PAXIL CR Bioequivalence Study
Started Jul 2008
166 enrolled
Depressive Disorder
Clinical Evaluation of BRL29060A (Paroxetine Hydrochloride Hydrate) in Posttraumatic Stress Disorder (PTSD)
Started Jan 2008
5 enrolled
Post-Traumatic Stress DisorderStress Disorders, Post-Traumatic
Paroxetine Hydrochloride 40 mg Tablets Under Fasting Conditions
Started Oct 2002
50 enrolled
Healthy